Logo image of MERY.PA

MERCIALYS (MERY.PA) Stock Fundamental Analysis

Europe - EPA:MERY - FR0010241638 - REIT

11 EUR
+0.04 (+0.36%)
Last: 9/19/2025, 7:00:00 PM
Fundamental Rating

4

MERY gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 40 industry peers in the Diversified REITs industry. MERY has a medium profitability rating, but doesn't score so well on its financial health evaluation. MERY has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

In the past year MERY was profitable.
MERY had a positive operating cash flow in the past year.
Each year in the past 5 years MERY has been profitable.
Each year in the past 5 years MERY had a positive operating cash flow.
MERY.PA Yearly Net Income VS EBIT VS OCF VS FCFMERY.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

1.2 Ratios

With a Return On Assets value of 1.28%, MERY is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
The Return On Equity of MERY (5.46%) is comparable to the rest of the industry.
MERY has a worse Return On Invested Capital (2.81%) than 65.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MERY is in line with the industry average of 3.43%.
Industry RankSector Rank
ROA 1.28%
ROE 5.46%
ROIC 2.81%
ROA(3y)2.28%
ROA(5y)2.51%
ROE(3y)7.45%
ROE(5y)8.62%
ROIC(3y)4.41%
ROIC(5y)4.49%
MERY.PA Yearly ROA, ROE, ROICMERY.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

MERY has a Profit Margin of 17.79%. This is comparable to the rest of the industry: MERY outperforms 42.50% of its industry peers.
MERY's Profit Margin has declined in the last couple of years.
MERY has a Operating Margin of 43.31%. This is in the lower half of the industry: MERY underperforms 77.50% of its industry peers.
MERY's Operating Margin has declined in the last couple of years.
MERY has a Gross Margin of 95.26%. This is amongst the best in the industry. MERY outperforms 90.00% of its industry peers.
In the last couple of years the Gross Margin of MERY has remained more or less at the same level.
Industry RankSector Rank
OM 43.31%
PM (TTM) 17.79%
GM 95.26%
OM growth 3Y-0.44%
OM growth 5Y-1.55%
PM growth 3Y-6.05%
PM growth 5Y-8.66%
GM growth 3Y1.08%
GM growth 5Y0.54%
MERY.PA Yearly Profit, Operating, Gross MarginsMERY.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so MERY is destroying value.
Compared to 1 year ago, MERY has less shares outstanding
MERY has more shares outstanding than it did 5 years ago.
MERY has a worse debt/assets ratio than last year.
MERY.PA Yearly Shares OutstandingMERY.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
MERY.PA Yearly Total Debt VS Total AssetsMERY.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

MERY has an Altman-Z score of 0.52. This is a bad value and indicates that MERY is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.52, MERY is doing worse than 75.00% of the companies in the same industry.
The Debt to FCF ratio of MERY is 11.36, which is on the high side as it means it would take MERY, 11.36 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MERY (11.36) is comparable to the rest of the industry.
MERY has a Debt/Equity ratio of 2.29. This is a high value indicating a heavy dependency on external financing.
The Debt to Equity ratio of MERY (2.29) is worse than 92.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.29
Debt/FCF 11.36
Altman-Z 0.52
ROIC/WACC0.52
WACC5.45%
MERY.PA Yearly LT Debt VS Equity VS FCFMERY.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

MERY has a Current Ratio of 1.11. This is a normal value and indicates that MERY is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of MERY (1.11) is better than 82.50% of its industry peers.
A Quick Ratio of 1.11 indicates that MERY should not have too much problems paying its short term obligations.
The Quick ratio of MERY (1.11) is better than 82.50% of its industry peers.
Industry RankSector Rank
Current Ratio 1.11
Quick Ratio 1.11
MERY.PA Yearly Current Assets VS Current LiabilitesMERY.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

3

3. Growth

3.1 Past

The earnings per share for MERY have decreased strongly by -64.87% in the last year.
The earnings per share for MERY have been decreasing by -10.10% on average. This is quite bad
The Revenue for MERY has decreased by -34.45% in the past year. This is quite bad
MERY shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -1.32% yearly.
EPS 1Y (TTM)-64.87%
EPS 3Y-4.95%
EPS 5Y-10.1%
EPS Q2Q%-61.58%
Revenue 1Y (TTM)-34.45%
Revenue growth 3Y1.39%
Revenue growth 5Y-1.32%
Sales Q2Q%-3.09%

3.2 Future

MERY is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 3.43% yearly.
The Revenue is expected to grow by 3.02% on average over the next years.
EPS Next Y7.79%
EPS Next 2Y5.18%
EPS Next 3Y3.43%
EPS Next 5YN/A
Revenue Next Year2.64%
Revenue Next 2Y3.96%
Revenue Next 3Y3.02%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
MERY.PA Yearly Revenue VS EstimatesMERY.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
MERY.PA Yearly EPS VS EstimatesMERY.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

MERY is valuated quite expensively with a Price/Earnings ratio of 32.35.
Based on the Price/Earnings ratio, MERY is valued a bit more expensive than 67.50% of the companies in the same industry.
MERY's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 27.38.
With a Price/Forward Earnings ratio of 8.83, the valuation of MERY can be described as very reasonable.
85.00% of the companies in the same industry are more expensive than MERY, based on the Price/Forward Earnings ratio.
MERY's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.86.
Industry RankSector Rank
PE 32.35
Fwd PE 8.83
MERY.PA Price Earnings VS Forward Price EarningsMERY.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MERY is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of MERY indicates a rather cheap valuation: MERY is cheaper than 90.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 6.81
EV/EBITDA 17.05
MERY.PA Per share dataMERY.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)4.15
PEG (5Y)N/A
EPS Next 2Y5.18%
EPS Next 3Y3.43%

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.12%, MERY is a good candidate for dividend investing.
MERY's Dividend Yield is rather good when compared to the industry average which is at 5.58. MERY pays more dividend than 100.00% of the companies in the same industry.
MERY's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 9.12%

5.2 History

The dividend of MERY decreases each year by -1.82%.
Dividend Growth(5Y)-1.82%
Div Incr Years4
Div Non Decr Years4
MERY.PA Yearly Dividends per shareMERY.PA Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6 0.8 1

5.3 Sustainability

MERY pays out 297.27% of its income as dividend. This is not a sustainable payout ratio.
DP297.27%
EPS Next 2Y5.18%
EPS Next 3Y3.43%
MERY.PA Yearly Income VS Free CF VS DividendMERY.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
MERY.PA Dividend Payout.MERY.PA Dividend Payout, showing the Payout Ratio.MERY.PA Dividend Payout.PayoutRetained Earnings

MERCIALYS

EPA:MERY (9/19/2025, 7:00:00 PM)

11

+0.04 (+0.36%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)07-24 2025-07-24
Earnings (Next)02-10 2026-02-10/amc
Inst Owners44.2%
Inst Owner ChangeN/A
Ins Owners0.26%
Ins Owner ChangeN/A
Market Cap1.03B
Analysts75.71
Price Target12.94 (17.64%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 9.12%
Yearly Dividend0.99
Dividend Growth(5Y)-1.82%
DP297.27%
Div Incr Years4
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)3.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-4.03%
EPS NY rev (3m)-4.03%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE 32.35
Fwd PE 8.83
P/S 5.84
P/FCF 6.81
P/OCF 6.81
P/B 1.79
P/tB 1.87
EV/EBITDA 17.05
EPS(TTM)0.34
EY3.09%
EPS(NY)1.25
Fwd EY11.33%
FCF(TTM)1.61
FCFY14.68%
OCF(TTM)1.61
OCFY14.68%
SpS1.88
BVpS6.13
TBVpS5.88
PEG (NY)4.15
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.28%
ROE 5.46%
ROCE 3.83%
ROIC 2.81%
ROICexc 3.61%
ROICexgc 3.67%
OM 43.31%
PM (TTM) 17.79%
GM 95.26%
FCFM 85.79%
ROA(3y)2.28%
ROA(5y)2.51%
ROE(3y)7.45%
ROE(5y)8.62%
ROIC(3y)4.41%
ROIC(5y)4.49%
ROICexc(3y)4.94%
ROICexc(5y)5.16%
ROICexgc(3y)4.95%
ROICexgc(5y)5.17%
ROCE(3y)6%
ROCE(5y)6.11%
ROICexcg growth 3Y4.57%
ROICexcg growth 5Y0.29%
ROICexc growth 3Y4.59%
ROICexc growth 5Y0.28%
OM growth 3Y-0.44%
OM growth 5Y-1.55%
PM growth 3Y-6.05%
PM growth 5Y-8.66%
GM growth 3Y1.08%
GM growth 5Y0.54%
F-Score5
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 2.29
Debt/FCF 11.36
Debt/EBITDA 9.75
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 1.3
Cash Conversion 111.91%
Profit Quality 482.16%
Current Ratio 1.11
Quick Ratio 1.11
Altman-Z 0.52
F-Score5
WACC5.45%
ROIC/WACC0.52
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)300.14%
Profit Quality(5y)255.17%
High Growth Momentum
Growth
EPS 1Y (TTM)-64.87%
EPS 3Y-4.95%
EPS 5Y-10.1%
EPS Q2Q%-61.58%
EPS Next Y7.79%
EPS Next 2Y5.18%
EPS Next 3Y3.43%
EPS Next 5YN/A
Revenue 1Y (TTM)-34.45%
Revenue growth 3Y1.39%
Revenue growth 5Y-1.32%
Sales Q2Q%-3.09%
Revenue Next Year2.64%
Revenue Next 2Y3.96%
Revenue Next 3Y3.02%
Revenue Next 5YN/A
EBIT growth 1Y-47.18%
EBIT growth 3Y0.95%
EBIT growth 5Y-2.84%
EBIT Next Year32.15%
EBIT Next 3Y11.4%
EBIT Next 5YN/A
FCF growth 1Y12.87%
FCF growth 3Y5.97%
FCF growth 5Y0.83%
OCF growth 1Y12.87%
OCF growth 3Y5.97%
OCF growth 5Y0.83%